AMANDA MURPHY: Open Payments
NPI 1740822329 · DANVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,990 in 95 payments from 20 companies in 2025. Trend: 2023 $2,137 · 2024 $2,135 · 2025 $1,990
Food & beverage: $1,990
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $533 |
| Madrigal Pharmaceuticals | 7 | $230 |
| Ardelyx, Inc. | 6 | $178 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $172 |
| GENZYME CORPORATION | 10 | $153 |
| EVOKE PHARMA, INC. | 1 | $120 |
| Gilead Sciences, Inc. | 4 | $96 |
| Verona Pharma, Inc. | 4 | $87 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $83 |
| Regeneron Healthcare Solutions, Inc. | 3 | $72 |
Products named: RINVOQ, REZDIFFRA, DUPIXENT, IBSRELA, XIFAXAN, LINZESS, Ohtuvayre, ENTYVIO.
Industry payments across KY — which companies pay providers there.
